期刊文献+

明胶酶B及其组织金属蛋白酶抑制剂与食管癌生物学行为的关系

Relationship Between Gelatin B as well as Its Tissue Inhibitor of Metalloproteinase and the Biological Behavior of Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的 研究明胶酶B(gelatinB)及其相应的组织金属蛋白酶抑制剂 -1(TIMP -1)在食管癌组织中的表达及其在细胞浸润转移过程中的作用。方法 采用免疫组织化学链霉素抗生物素蛋白 -过氧化物酶 (S -P)法检测 5 0例食管癌组织中明胶酶B及TIMP -1的表达。结果 明胶酶B在食管癌组织中的阳性表达率为 76.0 % ,其表达与淋巴结转移呈正相关 (Pearson列联系数为 0 .3 43 ,P <0 .0 5 ) ,TIMP -1在食管癌组织中的阳性表达率为 3 0 .0 % ,其表达与淋巴结转移呈负相关 (Pearson列联系数为0 .3 3 3 ,P <0 .0 5 )。结论 明胶酶B促进食管癌转移 ,TIMP -1对食管癌有独立的抑制作用。通过检测食管癌组织中的明胶酶B及TIMP -1的表达 。 Objective To investigation the expression of gelatin B and its tissue inhibitor of metalloproteinase 1(TIMP 1) in esophageal squamous carcinoma(ESC) and their important regular roles in the process of tumor invasion and metastasis.Methods The expression of Gelatin B and TIMP 1 were detected by immunohistochemistry(the method of streptoridin peroxidase,S P) in 50 cases with esophageal carcinomas.Results The expression rate of Gelatin B in ESC was76.0%,which was positively associated with lymph node metastasis(Pearson contingency coefficient were 0.343, P <0.05).The expression rate of TIMP 1 in ESC was 30.0%,which was negatively correlated with the lymph node metastasis(Pearson contingency coefficient were 0.333,respectively P < 0.05 ).Conclusion Gelatin B promotes tumor metastasis while TIMP 1 inhibits it.Examination of Gelatin B and TIMP 1 in ESC may predict the prognosis.
出处 《实用癌症杂志》 2003年第2期155-157,共3页 The Practical Journal of Cancer
关键词 食管癌 生物学行为 明胶酶B 组织金属蛋白酶抑制剂-1 肿瘤转移 免疫组织化学 预后 Esophageal cancer Gelatin B Tissue inhibitor of metalloproteinase 1(TTMP 1) Metastasis Immunohistochemistry
  • 相关文献

参考文献8

  • 1[1]Kleiner DE,Stetler-stevenson WG,et al. Matrix metalloproteinase and metastasis[J]. Cancer Chmother Pharmacol, 1999,43 (suppl) :42.
  • 2[2]Tsuchiya Y, Sato H, Endo Y, et al. Tissue inhibitor of metalloproteinase-1 is a negative regulatorof the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo[J ]. Cancer Res, 1993,53(6): 1397.
  • 3[3]Aznzvoorian S, Murphy AN,Stetler Stevenson WG,et al. Molecular aspects of tumor cell invasion and metastasis [J]. Cancer, 1993,71(4): 1368.
  • 4[4]Kenichi O,Tetsuo N,Kyoichi N,et al. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell cacinomas[J]. Cancer, 2000,88(10):2201.
  • 5[5]Murray GI,Duncan ME,O Neil P,et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer [J]. J Pat hol, 1998,185 (3): 256.
  • 6[6]Masaki M,Koshi M,Noriaki S,et al. Prognostic impact of tissue inhibitor of matrix metall-oproteinase-1 in esophageal carcinoma[J]. Int J Cancer, 2000,88 (4): 575.
  • 7[7]Bertaux B,Hornebeck W,Eisen A.Z,et al. Growth stimulation of human keratinooyces by tissue inhibitor of metalloproteinase[J]. J Invest Dermayol, 1991,97(4):679.
  • 8[8]Hayakawa T,Yamashita K,Kishi J,et al. Tissue inhibitor of metalloproteinase from human bone morrow stromal cell line KM102 has erythroid-potentiating activity, suggesting its possible bifunctional role in the hematopoieticmicroenviroment [J ]. FEBS Lett, 1990,286(1): 125.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部